VivoSeq
Nephrology

Dialysis

0

Pipeline Programs

5

Active Trials

9

Companies Involved

Dialysis is an early-stage landscape with 0 programs across 9 companies. The most active players are Sanofi, Merck & Co., Bayer.

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

88/100

Attrition Rate

9/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

35

clinical trials

Completed21 · 60%
Unknown status6 · 17%
Recruiting4 · 11%
Terminated2 · 6%
Withdrawn1 · 3%
Active, not recruiting1 · 3%

Trial Activity

35 trials

Monitoring of the Bone Free Flaps With Microdialysis
Recruiting··N/A·NCT03935139·40 enrolled
DIALYSIS-TIR Study
Active, not recruiting·UUniversity of Texas Southwestern Medical Center·Phase 4·NCT06042153·43 enrolled
Microdialysis and Pharmacokinetic Study of TR-701
Completed·Merck & Co. logoMerck & Co.·Phase 1·NCT00666601·15 enrolled
Long-term Pre-dialysis Extension in Europe and Asia Pacific
Completed·Bayer logoBayer·Phase 2·NCT02055482·166 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)